698998-85-5Relevant articles and documents
REMEDY FOR AUTOIMMUNE DISEASES
-
Page/Page column 31-32, (2008/06/13)
In the present invention, there are disclosed a therapeutic agent for the treatment of a disease in which the suppression of Th1 cytokine production is therapeutically effective and/or a disease in which the suppression of autoantibody production is therapeutically effective, a therapeutic agent for the eradicative treatment of these diseases, and an agent for inhibiting the progress of these diseases, comprising (i) a proanthocyanidin with a polymerization degree of at least 4 or (ii) a plant material extract containing a proanthocyanidin as an active ingredient.
Oligomeric flavanoids. Part 27. Interflavanyl bond formation in procyanidins under neutral conditions
Steynberg, Petrus J.,Nel, Reinier J.J.,Van Rensburg, Hendrik,Bezuidenhoudt, Barend C.B.,Ferreira, Daneel
, p. 8153 - 8158 (2007/10/03)
Dimethyl(methylthio)sulfonium tetrafluoroborate (DMTSF) and silver tetrafluoroborate (AgBF4) activate the C4-S bond in the 4-thioethers of flavan-3-ols toward carbon nucleophiles to permit formation of the interflavanyl bond in procyanidins under neutral conditions.
FLAVAN-3-OL AND PROCYANIDIN GLYCOSIDES FROM QUERCUS MIYAGII
Ishimaru, Kanji,Nonaka, Gen-Ichiro,Nishioka, Itsuo
, p. 1167 - 1170 (2007/10/02)
A chemical examination of the leaves and bark of Quercus miyagii has led to the isolation and characterization of two flavan-3-ol glycosides and two procyanidin rhamnosides in which the sugar residue is located at C-3. - Key Word Index: Quercus miyagii; Fagaceae; flavan-3-ol glycosides; procyanidin rhamnosides; catechin; tannin.